x

Fuss Brands Corp. (OTC:FBDS)

Health Care/Life Sciences • Pharmaceuticals
CIK 926844
Company

Fuss Brands Corp. engages in the research, manufacture and distribution of botanical products, bio-pharmaceutical products, and traditional Chinese medicines. Its products include Siberian ginseng, other plant-based anti-depression and nerve regulation products, botanical antibiotics, badger oil, and ginseng and deer antler extracts. The company was founded on August 18, 1988 and is headquartered in New York, NY.

Address
80 Broad Street
5th floor
New York, New York 10004
Employees
485
Stock Info
Close
$0.1500
Day Range
0.0600 - 0.0600
52 Week Range
0.0300 - 1.1000
Average volume
47.71
Short Interest
N/A (N/A)
% of Float Shorted
N/A
Market Cap
N/A
Revenue
$72.71M
Net Income
$25.92M
2020 Sales Growth
N/A
Rev. per Employee
$149.93K
P/E Ratio
N/A
EPS
N/A
Yield
N/A
Dividend
N/A
Ex-Dividend Date
N/A
Key Executives
Board Of Directors
Chairman & Chief Executive Officer
Cheskel Meisels
SEC filings
DateFormEvent
6 Sep, 2024 10-Q
27 Jun, 2024 10-Q
13 Jun, 2024 NT 10-Q
8 May, 2024 8-K
18 Mar, 2024 10-Q
5 Feb, 2024 10-K
29 Jan, 2024 NT 10-K
11 Jan, 2024 8-K CEO Change
5 Sep, 2023 10-Q
12 Jun, 2023 10-Q
9 Mar, 2023 10-Q
2 Mar, 2023 8-K
27 Jan, 2023 8-K
27 Jan, 2023 10-K
18 Jan, 2023 D/A
4 Jan, 2023 8-K/A
5 Dec, 2022 8-K
1 Nov, 2022 8-K
8 Sep, 2022 10-Q
26 Aug, 2022 8-K
14 Jun, 2022 D
8 Jun, 2022 10-Q
28 Mar, 2022 10-K/A
28 Feb, 2022 10-K/A
25 Feb, 2022 10-Q
16 Dec, 2021 10-K
23 Nov, 2021 10-Q
23 Nov, 2021 10-K
23 Nov, 2021 10-Q
29 Oct, 2021 15-15D
20 Sep, 2021 10-Q
13 Sep, 2021 NT 10-Q
25 Aug, 2021 8-K CEO Change
12 Aug, 2021 10-Q
12 Aug, 2021 10-K
14 Jul, 2021 10-Q
14 Jul, 2021 10-Q
14 Jul, 2021 10-K
17 Feb, 2021 8-K CEO Change
Last update:2024-03-08 12:05:31.624085
Fuss Brands Corp. by TradingView

Sign Up to Subscribe